Physician profile
Daniel L Hall
NPI 1316050958
$1,225.30
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $227 · 2021: $391 · 2022: $317 · 2024: $25.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.98 | 2019-2022 | |
| Pfizer INC. | $237.67 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $126.45 | 2019-2022 | |
| Exeltis, USA INC. | $84.99 | 2019-2022 | |
| Lupin INC. | $70.58 | 2020-2021 | |
| Therapeuticsmd, INC. | $69.27 | 2020-2022 | |
| Myovant Sciences INC. | $58.48 | 2021-2022 | |
| Agile Therapeutics, INC. | $51.68 | 2021-2022 | |
| Evofem Biosciences, INC. | $51.31 | 2020-2022 | |
| Organon LLC | $51.25 | 2022 | |
| Alydia Health | $29.15 | 2021 | |
| Sanofi Pasteur INC. | $25.05 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.30 | 2019 | |
| Avion Pharmaceuticals | $15.52 | 2019 | |
| Z-Medica, LLC | $13.14 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $12.91 | 2019 | |
| Mayne Pharma Commercial LLC | $12.79 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.69 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.